These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 24365858
1. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis. Iwagami M, Yasunaga H, Doi K, Horiguchi H, Fushimi K, Matsubara T, Yahagi N, Noiri E. Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858 [Abstract] [Full Text] [Related]
4. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival. Sawa N, Ubara Y, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hoshino J, Suwabe T, Uchida N, Wake A, Taniguchi S, Takaichi K. Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903 [Abstract] [Full Text] [Related]
5. Polymyxin B hemoperfusion: matching the cure to the disease. Cruz DN. Crit Care Med; 2014 May; 42(5):1309-10. PubMed ID: 24736351 [No Abstract] [Full Text] [Related]
6. Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis. Iwagami M, Yasunaga H, Noiri E, Horiguchi H, Fushimi K, Matsubara T, Yahagi N, Nangaku M, Doi K. Blood Purif; 2016 May; 42(1):9-17. PubMed ID: 26918904 [Abstract] [Full Text] [Related]
15. Rescue therapy with polymyxin B hemoperfusion in high-dose vasopressor therapy refractory septic shock. Monti G, Terzi V, Calini A, Di Marco F, Cruz D, Pulici M, Brioschi P, Vesconi S, Fumagalli R, Casella G. Minerva Anestesiol; 2015 May; 81(5):516-25. PubMed ID: 25319136 [Abstract] [Full Text] [Related]
16. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853 [Abstract] [Full Text] [Related]
18. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial. Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, Palevsky PM, Weisberg LS, Schorr CA, Trzeciak S, Walker PM, EUPHRATES Trial Investigators. JAMA; 2018 Oct 09; 320(14):1455-1463. PubMed ID: 30304428 [Abstract] [Full Text] [Related]
19. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, Mimoz O, Coudroy R, Ferrandière M, Kipnis E, Vela C, Chevallier S, Mallat J, Robert R, ABDOMIX Group. Intensive Care Med; 2015 Jun 09; 41(6):975-84. PubMed ID: 25862039 [Abstract] [Full Text] [Related]
20. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion. Ishizuka M, Tago K, Kubota K. Surgery; 2014 Jul 09; 156(1):168-75. PubMed ID: 24929766 [Abstract] [Full Text] [Related] Page: [Next] [New Search]